Evolus, Inc. Common Stock

As of June 30, 2026, Evolus, Inc. carries a market capitalization of 402.95M, placing it among publicly traded companies globally. Its enterprise value stands at 507.66M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Evolus, Inc.'s next confirmed earnings release is scheduled for November 4, 2026.

As of June 30, 2026, Evolus, Inc. has 66.01M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 1.44, and the price-to-book ratio stands at -14.90.

These figures are as of June 30, 2026. The EV/Sales ratio of 1.83 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 507.66M versus a market cap of 402.95M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Evolus, Inc. maintains a current ratio of 1.70, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -533.29, indicating conservative leverage, while an interest coverage ratio of -0.52 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -14.40, reflecting losses generated across the asset base. The company generates approximately 830,650.51 in revenue per employee across its workforce of 333.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.13 indicates how many times Evolus, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Evolus, Inc. recorded 572,446.20 in income tax expense. The company reported a pretax loss of -29.48M and -30.05M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Evolus, Inc.'s stock has gained approximately 11.93% over the past 52 weeks. The 50-day moving average sits at 7.07, while the 200-day moving average is 5.42.

Over the twelve months ended June 30, 2026, Evolus, Inc. generated 277.02M in revenue and converted that into -30.05M in net income, yielding earnings per share of -0.46. EBITDA reached -7.37M, while operating income came in at -18.04M.

As of June 30, 2026, Evolus, Inc. holds 39.54M in cash and equivalents against 144.25M in total debt, resulting in a net debt position of 97.66M. Total book value stands at -27.05M, with working capital of 60.23M providing operational flexibility.

Evolus, Inc. produced -13.46M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -2.54M in capital expenditures, free cash flow totaled -16.00M - equivalent to -0.25 per share.

Over the twelve months ended June 30, 2026, Evolus, Inc. posted a gross margin of 66.74, reflecting its pricing power and cost economics. The operating margin of -6.51 and net profit margin of -10.85 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -4.01: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -1.21, meaning Evolus, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Evolus, Inc. has an Altman Z-Score of -2.44, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.